Cargando…
Expanded genetic insight and clinical experience of DNMT1-complex disorder
OBJECTIVE: To report novel causal mutations, expanded clinical phenotypes, and clinical management of DNA methyltransferase 1 (DNMT1)-complex disorder. METHODS: Neurophysiologic testing, imaging, and genetic findings were summarized in clinical context for 5 cases with DNMT1-complex disorder. RESULT...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357420/ https://www.ncbi.nlm.nih.gov/pubmed/32754641 http://dx.doi.org/10.1212/NXG.0000000000000456 |
_version_ | 1783558682461601792 |
---|---|
author | Bi, Hongyan Hojo, Kaori Watanabe, Masashi Yee, Christina Maski, Kiran Saba, Sadaf Graff-Radford, Jonathan Machulda, Mary M. St Louis, Erik K. Humes, Ilona Spitsyna Flanagan, Eoin P. Nicolau, Stefan Jones, David T. Patterson, Marc C. Kotagal, Suresh Raz, Yael Niu, Zhiyv Li, Jun Klein, Christopher J. |
author_facet | Bi, Hongyan Hojo, Kaori Watanabe, Masashi Yee, Christina Maski, Kiran Saba, Sadaf Graff-Radford, Jonathan Machulda, Mary M. St Louis, Erik K. Humes, Ilona Spitsyna Flanagan, Eoin P. Nicolau, Stefan Jones, David T. Patterson, Marc C. Kotagal, Suresh Raz, Yael Niu, Zhiyv Li, Jun Klein, Christopher J. |
author_sort | Bi, Hongyan |
collection | PubMed |
description | OBJECTIVE: To report novel causal mutations, expanded clinical phenotypes, and clinical management of DNA methyltransferase 1 (DNMT1)-complex disorder. METHODS: Neurophysiologic testing, imaging, and genetic findings were summarized in clinical context for 5 cases with DNMT1-complex disorder. RESULTS: We identified 2 novel DNMT1 mutations (p.E510K and p.P1546A) by whole-exome sequencing (WES). Case 1 (p.E510K) presented with childhood ataxia, treatment-refractory seizures, and rapid cognitive decline in his 50s. Case 2 also had childhood onset and presented with seizures, language regression, hearing loss, narcolepsy with cataplexy symptoms, optic atrophy, sensory neuropathy, and hypogammaglobulinemia requiring IV immunoglobulin. Case 2 (p.P1546A) was identified with a de novo and the first mutation residing outside the targeting sequence domain. Case 3 (p.A570V) had paralytic asymmetric onset attacks triggered by emotionality and lasting sometimes for weeks. Neuropsychological testing showed executive dysfunction localizing to frontosubcortical and frontoparietal structures. He gradually developed left predominant brain atrophy. MRI showed T2 hyperintense lesions that enhanced on T1 postgadolinium images, and brain PET showed hypometabolism in atrophied regions. Case 4 (p.T497P) underwent left cochlear implant, resulting in significant hearing improvements at all tested frequencies (250–6,000 Hz). Case 5 (p.Y511H) had profound gait ataxia with posterior column atrophy of the spinal cord and abnormal evoked potentials primarily affecting the fasciculus gracilis. CONCLUSIONS: Broader application of WES further expands genotype-phenotype correlations of DNMT1-complex disorder. Two mutations are identified with early childhood onsets. The expanded new phenotypes include asymmetric brain hemiatrophy with parenchymal gadolinium enhancement, spinal cord atrophy, prolonged cataplectic spells, and hypogammaglobulinemia. Hearing loss treatment by cochlear implantation is helpful and should be considered. |
format | Online Article Text |
id | pubmed-7357420 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer |
record_format | MEDLINE/PubMed |
spelling | pubmed-73574202020-08-03 Expanded genetic insight and clinical experience of DNMT1-complex disorder Bi, Hongyan Hojo, Kaori Watanabe, Masashi Yee, Christina Maski, Kiran Saba, Sadaf Graff-Radford, Jonathan Machulda, Mary M. St Louis, Erik K. Humes, Ilona Spitsyna Flanagan, Eoin P. Nicolau, Stefan Jones, David T. Patterson, Marc C. Kotagal, Suresh Raz, Yael Niu, Zhiyv Li, Jun Klein, Christopher J. Neurol Genet Article OBJECTIVE: To report novel causal mutations, expanded clinical phenotypes, and clinical management of DNA methyltransferase 1 (DNMT1)-complex disorder. METHODS: Neurophysiologic testing, imaging, and genetic findings were summarized in clinical context for 5 cases with DNMT1-complex disorder. RESULTS: We identified 2 novel DNMT1 mutations (p.E510K and p.P1546A) by whole-exome sequencing (WES). Case 1 (p.E510K) presented with childhood ataxia, treatment-refractory seizures, and rapid cognitive decline in his 50s. Case 2 also had childhood onset and presented with seizures, language regression, hearing loss, narcolepsy with cataplexy symptoms, optic atrophy, sensory neuropathy, and hypogammaglobulinemia requiring IV immunoglobulin. Case 2 (p.P1546A) was identified with a de novo and the first mutation residing outside the targeting sequence domain. Case 3 (p.A570V) had paralytic asymmetric onset attacks triggered by emotionality and lasting sometimes for weeks. Neuropsychological testing showed executive dysfunction localizing to frontosubcortical and frontoparietal structures. He gradually developed left predominant brain atrophy. MRI showed T2 hyperintense lesions that enhanced on T1 postgadolinium images, and brain PET showed hypometabolism in atrophied regions. Case 4 (p.T497P) underwent left cochlear implant, resulting in significant hearing improvements at all tested frequencies (250–6,000 Hz). Case 5 (p.Y511H) had profound gait ataxia with posterior column atrophy of the spinal cord and abnormal evoked potentials primarily affecting the fasciculus gracilis. CONCLUSIONS: Broader application of WES further expands genotype-phenotype correlations of DNMT1-complex disorder. Two mutations are identified with early childhood onsets. The expanded new phenotypes include asymmetric brain hemiatrophy with parenchymal gadolinium enhancement, spinal cord atrophy, prolonged cataplectic spells, and hypogammaglobulinemia. Hearing loss treatment by cochlear implantation is helpful and should be considered. Wolters Kluwer 2020-06-12 /pmc/articles/PMC7357420/ /pubmed/32754641 http://dx.doi.org/10.1212/NXG.0000000000000456 Text en Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Article Bi, Hongyan Hojo, Kaori Watanabe, Masashi Yee, Christina Maski, Kiran Saba, Sadaf Graff-Radford, Jonathan Machulda, Mary M. St Louis, Erik K. Humes, Ilona Spitsyna Flanagan, Eoin P. Nicolau, Stefan Jones, David T. Patterson, Marc C. Kotagal, Suresh Raz, Yael Niu, Zhiyv Li, Jun Klein, Christopher J. Expanded genetic insight and clinical experience of DNMT1-complex disorder |
title | Expanded genetic insight and clinical experience of DNMT1-complex disorder |
title_full | Expanded genetic insight and clinical experience of DNMT1-complex disorder |
title_fullStr | Expanded genetic insight and clinical experience of DNMT1-complex disorder |
title_full_unstemmed | Expanded genetic insight and clinical experience of DNMT1-complex disorder |
title_short | Expanded genetic insight and clinical experience of DNMT1-complex disorder |
title_sort | expanded genetic insight and clinical experience of dnmt1-complex disorder |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357420/ https://www.ncbi.nlm.nih.gov/pubmed/32754641 http://dx.doi.org/10.1212/NXG.0000000000000456 |
work_keys_str_mv | AT bihongyan expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder AT hojokaori expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder AT watanabemasashi expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder AT yeechristina expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder AT maskikiran expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder AT sabasadaf expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder AT graffradfordjonathan expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder AT machuldamarym expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder AT stlouiserikk expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder AT humesilonaspitsyna expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder AT flanaganeoinp expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder AT nicolaustefan expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder AT jonesdavidt expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder AT pattersonmarcc expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder AT kotagalsuresh expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder AT razyael expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder AT niuzhiyv expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder AT lijun expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder AT kleinchristopherj expandedgeneticinsightandclinicalexperienceofdnmt1complexdisorder |